Brainsway Ltd. ADR (BWAY)
NASDAQ (NMS) NASDAQ (NMS) Primary 
Here's Why Momentum in Brainsway (BWAY) Should Keep going
If you are looking for stocks that are well positioned to maintain their recent uptrend, Brainsway (BWAY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
BrainsWay: Strong Execution, But Valuation Limits Upside
BrainsWay has delivered strong revenue growth, expanding its leasing model and recurring revenue base. BWAY reported 27% annual revenue growth, 75.4% gross margin, and issued 2026 guidance for $66–68M revenue and $12–14M adjusted EBITDA. The leasing model drives high-margin, stable recurring revenue with 93% customer retention and $70M in remaining performance obligations.
Brainsway (NASDAQ:BWAY) Reaches New 12-Month High on Better-Than-Expected Earnings
Brainsway Ltd. Sponsored ADR (NASDAQ: BWAY - Get Free Report) shares hit a new 52-week high during trading on Wednesday following a stronger than expected earnings report. The company traded as high as $13.75 and last traded at $13.29, with a volume of 102207 shares. The stock had previously closed at $12.71. The company reported $0.14
BWAY Shares Gain on Optum Expanding Deep TMS Coverage for Teens
BrainsWay stock rises after Optum expands Deep TMS coverage for adolescents, boosting reimbursement visibility.
BrainsWay Ltd. (BWAY) Analyst/Investor Day Transcript
BrainsWay Ltd. (BWAY) Analyst/Investor Day Transcript
BrainsWay Ltd. (BWAY) Q3 2025 Earnings Call Transcript
BrainsWay Ltd. ( BWAY ) Q3 2025 Earnings Call November 11, 2025 8:30 AM EST Company Participants Hadar Levy - Chief Executive Officer Ido Marom - Chief Financial Officer Conference Call Participants Brian Ritchie - Lifesci Advisors, LLC Jeffrey Cohen - Ladenburg Thalmann & Co. Inc., Research Division Carl Byrnes - Northland Capital Markets, Research Division Raghuram Selvaraju - H.C.
Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run?
Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
BWAY Shares Gain on FDA Nod for Accelerated Deep TMS Depression Care
BrainsWay shares surge after the FDA cleared its accelerated Deep TMS protocol, offering faster depression treatment with strong clinical results.
BWAY Shares Rise on Strategic Investment in Neurolief's At-Home Care
BrainsWay's $5 million investment in Neurolief expands its mental health footprint with at-home depression treatment potential.
Brainsway Ltd. Sponsored ADR (BWAY) Hit a 52 Week High, Can the Run Continue?
Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Surging Earnings Estimates Signal Upside for Brainsway (BWAY) Stock
Brainsway Ltd. Sponsored ADR (BWAY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Wall Street Analysts Think Brainsway (BWAY) Could Surge 25.58%: Read This Before Placing a Bet
The mean of analysts' price targets for Brainsway (BWAY) points to a 25.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
